Budapest, Hungary

Endréné Flórian

This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar Nyrt. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Endréné Flórian. Retrieved from https://idiyas.com/inventor/endréné-flórian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Endréné Flórian: Innovator in Pharmaceutical Chemistry

Introduction

Endréné Flórian is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on piperazine derivatives.

Latest Patents

Flórian holds a patent for "Piperazine derivatives of dialkyl oxindoles." This invention focuses on new 3,3-disubstituted indol-2-one derivatives that are useful in treating or preventing diseases affecting the central nervous system, gastrointestinal system, and cardiovascular system. The patent includes various chemical structures and formulations that demonstrate the potential therapeutic applications of these compounds.

Career Highlights

Flórian is associated with Egis Gyogyszergyar Nyrt, a prominent pharmaceutical company in Hungary. His work at Egis has allowed him to explore and develop innovative solutions in drug formulation and design. His expertise in the field has led to advancements that benefit both the industry and patients.

Collaborations

Flórian has collaborated with notable colleagues, including Balázs Volk and József Barkóczy. These partnerships have fostered a collaborative environment that enhances research and development efforts within the pharmaceutical sector.

Conclusion

Endréné Flórian's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key figure in the industry. His work continues to impact the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…